Literature DB >> 11176784

Diabetes is not associated with longer survival in patients with lung cancer.

H Satoh, H Ishikawa, K Kurishima, M Ohtsuka, K Sekizawa.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11176784     DOI： 10.1001/archinte.161.3.485

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  9 in total

1.  Increased lung cancer risk among patients with pneumococcal pneumonia: a nationwide population-based cohort study.

Authors:  Te-Yu Lin; Wen-Yen Huang; Jung-Chung Lin; Cheng-Li Lin; Fung-Chang Sung; Chia-Hung Kao; Jun-Jun Yeh
Journal:  Lung       Date:  2013-10-23       Impact factor: 2.584

2.  Survival of patients with lung cancer and diabetes mellitus.

Authors:  Koichi Kurishima; Hiroko Watanabe; Hiroichi Ishikawa; Hiroaki Satoh; Nobuyuki Hizawa
Journal:  Mol Clin Oncol       Date:  2017-04-20

3.  Metformin and Not Diabetes Influences the Survival of Resected Early Stage NSCLC Patients.

Authors:  Samjot Singh Dhillon; Adrienne Groman; Alison Meagher; Todd Demmy; Graham W Warren; Sai Yendamuri
Journal:  J Cancer Sci Ther       Date:  2014-06-30

4.  Survival difference in NSCLC and SCLC patients with diabetes mellitus according to the first-line therapy.

Authors:  Kensuke Nakazawa; Koichi Kurishima; Tomohiro Tamura; Hiroichi Ishikawa; Hiroaki Satoh; Nobuyuki Hizawa
Journal:  Med Oncol       Date:  2013-01-10       Impact factor: 3.064

5.  Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer.

Authors:  Hisao Imai; Kyoichi Kaira; Keita Mori; Akira Ono; Hiroaki Akamatsu; Shunichi Matsumoto; Tetsuhiko Taira; Hirotsugu Kenmotsu; Hideyuki Harada; Tateaki Naito; Haruyasu Murakami; Masahiro Endo; Takashi Nakajima; Masanobu Yamada; Toshiaki Takahashi
Journal:  BMC Cancer       Date:  2015-12-21       Impact factor: 4.430

Review 6.  Diabetic lung disease: fact or fiction?

Authors:  Saeed Kolahian; Veronika Leiss; Bernd Nürnberg
Journal:  Rev Endocr Metab Disord       Date:  2019-09       Impact factor: 6.514

Review 7.  Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses.

Authors:  Pedro Barrios-Bernal; Zyanya Lucia Zatarain-Barrón; Norma Hernández-Pedro; Mario Orozco-Morales; Alejandra Olivera-Ramírez; Federico Ávila-Moreno; Ana Laura Colín-González; Andrés F Cardona; Rafael Rosell; Oscar Arrieta
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-24

8.  Small vessel ischemic disease of the brain and brain metastases in lung cancer patients.

Authors:  Peter J Mazzone; Nicola Marchi; Vince Fazio; J Michael Taylor; Thomas Masaryk; Luke Bury; Tarek Mekhail; Damir Janigro
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

9.  Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer.

Authors:  Oscar Arrieta; Edgar Varela-Santoyo; Enrique Soto-Perez-de-Celis; Roberto Sánchez-Reyes; Martha De la Torre-Vallejo; Saé Muñiz-Hernández; Andrés F Cardona
Journal:  BMC Cancer       Date:  2016-08-12       Impact factor: 4.430
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.